BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 30743173)

  • 21. Discovery of potent PTP1B inhibitors via structure-based drug design, synthesis and in vitro bioassay of Norathyriol derivatives.
    Xue W; Tian J; Wang XS; Xia J; Wu S
    Bioorg Chem; 2019 May; 86():224-234. PubMed ID: 30716620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
    Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B).
    Jin J; Ye X; Boateng D; Dai K; Ye F; Du P; Yu H
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2358-2363. PubMed ID: 31221555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-Phenylpropanoic acid-based phosphotyrosine (pTyr) mimetics: hit evolution to a novel orally active protein tyrosine phosphatase 1B (PTP1B) inhibitor.
    Tang YB; Liu JZ; Zhang SE; Du X; Nie F; Tian JY; Ye F; Huang K; Hu JP; Li Y; Xiao Z
    ChemMedChem; 2014 May; 9(5):918-21. PubMed ID: 24644278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study.
    Hidalgo-Figueroa S; Estrada-Soto S; Ramírez-Espinosa JJ; Paoli P; Lori G; León-Rivera I; Navarrete-Vázquez G
    Biomed Pharmacother; 2018 Nov; 107():1302-1310. PubMed ID: 30257345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
    Ramírez-Espinosa JJ; Rios MY; Paoli P; Flores-Morales V; Camici G; de la Rosa-Lugo V; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
    Eur J Med Chem; 2014 Nov; 87():316-27. PubMed ID: 25264584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTP1B inhibitors: synthesis and evaluation of difluoro-methylenephosphonate bioisosteres on a sulfonamide scaffold.
    Holmes CP; Li X; Pan Y; Xu C; Bhandari A; Moody CM; Miguel JA; Ferla SW; De Francisco MN; Frederick BT; Zhou S; Macher N; Jang L; Irvine JD; Grove JR
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2719-24. PubMed ID: 18372175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting inactive enzyme conformation: aryl diketoacid derivatives as a new class of PTP1B inhibitors.
    Liu S; Zeng LF; Wu L; Yu X; Xue T; Gunawan AM; Long YQ; Zhang ZY
    J Am Chem Soc; 2008 Dec; 130(50):17075-84. PubMed ID: 19012396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of 1,3,4-Thiadiazolyl-Containing Thiazolidine-2,4-dione Derivatives as Novel PTP1B Inhibitors with Antidiabetic Activity.
    Li M; Li H; Min X; Sun J; Liang B; Xu L; Li J; Wang SH; Xu X
    J Med Chem; 2024 May; 67(10):8406-8419. PubMed ID: 38723203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of protein tyrosine phosphatase 1B (PTP1B) inhibitors through De Novo Evoluton, synthesis, biological evaluation and molecular dynamics simulation.
    Wu J; Ma Y; Zhou H; Zhou L; Du S; Sun Y; Li W; Dong W; Wang R
    Biochem Biophys Res Commun; 2020 May; 526(1):273-280. PubMed ID: 32209254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.
    Meng G; Zheng M; Wang M; Tong J; Ge W; Zhang J; Zheng A; Li J; Gao L; Li J
    Eur J Med Chem; 2016 Oct; 122():756-769. PubMed ID: 27526040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
    Sun LP; Ma WP; Gao LX; Yang LL; Quan YC; Li J; Piao HR
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1199-204. PubMed ID: 23009604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.
    Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Darji B; Siriki Y; Bandyopadhyay D; Joharapurkar A; Kshirsagar S; Patel H; Shaikh M; Sairam KV; Patel P
    ChemMedChem; 2011 Jun; 6(6):1011-6. PubMed ID: 21506278
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined Ligand- and Receptor-Based Virtual Screening Methodology to Identify Structurally Diverse Protein Tyrosine Phosphatase 1B Inhibitors.
    Gimeno A; Ardid-Ruiz A; Ojeda-Montes MJ; Tomás-Hernández S; Cereto-Massagué A; Beltrán-Debón R; Mulero M; Valls C; Aragonès G; Suárez M; Pujadas G; Garcia-Vallvé S
    ChemMedChem; 2018 Sep; 13(18):1939-1948. PubMed ID: 30024103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy.
    Chen YT; Tang CL; Ma WP; Gao LX; Wei Y; Zhang W; Li JY; Li J; Nan FJ
    Eur J Med Chem; 2013 Nov; 69():399-412. PubMed ID: 24090912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico modeling of protein tyrosine phosphatase 1B inhibitors with cellular activity.
    Hu X
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6321-7. PubMed ID: 16996733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
    Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
    Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.
    Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of some N-(3-(1H-tetrazol-5-yl) phenyl)acetamide derivatives as novel non-carboxylic PTP1B inhibitors designed through bioisosteric modulation.
    Maheshwari N; Karthikeyan C; Bhadada SV; Sahi C; Verma AK; Hari Narayana Moorthy NS; Trivedi P
    Bioorg Chem; 2018 Oct; 80():145-150. PubMed ID: 29925050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
    Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
    Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.